ADAM9 and melanoma: Moreover, treatment of primary or metastatic melanoma cells with anti-miR-126 and/or 126* LNA oligonucleotides for 48 hours showed a significant increase in the levels of ADAM9 and MMP7 compared with negative control-treated cells as judged by western blot analysis.